Jared Carbone
Psychiatric/Mental Health · Greenville, SCNPI 1164810610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 355 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,072 and has fallen 92.8% since, to $220 in 2025. Among psychiatric/mental health clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 355 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$578
- Otsuka America Pharmaceutical, Inc.$556
- Sunovion Pharmaceuticals Inc.$439
- Teva Pharmaceuticals USA, Inc.$417
- Vanda Pharmaceuticals Inc.$399
- plus $3K from 22 others
What the payments were for
- Food & beverage$6,892100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 85 | $1,638 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $578 |
| Otsuka America Pharmaceutical, Inc. | 30 | $556 |
| Sunovion Pharmaceuticals Inc. | 22 | $439 |
| Teva Pharmaceuticals USA, Inc. | 14 | $417 |
| Vanda Pharmaceuticals Inc. | 19 | $399 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $371 |
| Alkermes, Inc. | 18 | $340 |
| Axsome Therapeutics, Inc. | 10 | $325 |
| Lundbeck LLC | 19 | $302 |
| Bausch Health US, LLC | 15 | $239 |
| Corium, LLC | 7 | $194 |
| Neurocrine Biosciences, Inc. | 11 | $156 |
| Supernus Pharmaceuticals, Inc. | 2 | $148 |
| Avanir Pharmaceuticals, Inc. | 9 | $139 |
| Novo Nordisk | 1 | $103 |
| Neos Therapeutics, LP | 5 | $88 |
| Merck | 5 | $74 |
| Johnson & Johnson | 4 | $73 |
| Tris Pharma Inc | 3 | $71 |
| Almatica Pharma LLC | 4 | $65 |
| Eisai Inc. | 4 | $57 |
| Arbor Pharmaceuticals, Inc. | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Gilead | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,895 in reported general payments places this provider in the 90th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 13 | $429 |
| Armodafinil | 16 | $416 |
| Buspirone Hcl | 17 | $212 |
| Clonazepam | 13 | $154 |
| Lamotrigine | 13 | $151 |
| Trazodone Hcl | 13 | $94 |
| Alprazolam | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Greenville
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- William HendricksGreenville$13K
- Carrie BallengerGreenville$11K
- Gregory SmithGreenville$9K
- Svetlana RobinsonGreenville$8K
- Anglique RichGreenville$6K
- Matthew HendricksGreenville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.